C07C 235/70
Carboxylic acid amides, the carbon skeleton of the acid part being further
Official title: having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
C07C235/70 (Carboxylic acid amides, the carbon skeleton of the acid part being further) appears on 969 US grants and 949 published applications in this corpus.
Search patents in C07C- Granted patents
- 969
- Published applications
- 949
- Assignees
- 601
- Inventors
- 2,890
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1980 | 1 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 1 | 0 |
| 1984 | 1 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 4 | 0 |
| 1990 | 5 | 0 |
| 1991 | 5 | 0 |
| 1992 | 16 | 0 |
| 1993 | 15 | 0 |
| 1994 | 15 | 0 |
| 1995 | 20 | 0 |
| 1996 | 19 | 0 |
| 1997 | 35 | 0 |
| 1998 | 32 | 0 |
| 1999 | 44 | 0 |
| 2000 | 25 | 0 |
| 2001 | 21 | 13 |
| 2002 | 45 | 39 |
| 2003 | 41 | 50 |
| 2004 | 19 | 53 |
| 2005 | 32 | 42 |
| 2006 | 25 | 22 |
| 2007 | 24 | 39 |
| 2008 | 21 | 36 |
| 2009 | 27 | 37 |
| 2010 | 31 | 40 |
| 2011 | 21 | 27 |
| 2012 | 18 | 37 |
| 2013 | 32 | 37 |
| 2014 | 35 | 70 |
| 2015 | 39 | 55 |
| 2016 | 55 | 66 |
| 2017 | 46 | 43 |
| 2018 | 35 | 44 |
| 2019 | 33 | 25 |
| 2020 | 31 | 29 |
| 2021 | 25 | 31 |
| 2022 | 19 | 20 |
| 2023 | 15 | 23 |
| 2024 | 10 | 28 |
| 2025 | 17 | 27 |
| 2026 | 13 | 16 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Tetracycline derivatives for treating neurodegenerative or neuroinflammatory diseases29 Sep 2026US 12,746,247 B2Institut Du Cerveau Et De La Moelle Epiniere
- Small molecule nicotinamide adenine dinucleotide modulators22 Sep 2026US 12,741,933 B2The Cleveland Clinic Foundation
- Cinnamamide derivatives and use thereof1 Sep 2026US 12,721,842 B2Korea Research Institute of Bioscience and Biotechnology
- Nitrogen-branched non-linear pegylated lipid containing a tertiary amine and application thereof18 Aug 2026US 12,708,675 B2Xiamen Sinopeg Biotech Co., Ltd.
- RXFP1 agonists18 Aug 2026US 12,709,594 B2Bristol-Myers Squibb Company
- Compounds and compositions for treating glucose hypometabolic disorders8 Oct 2026US 2026/0306523 A1Senovia Biosciences LLC
- Quaternary ammonium compounds6 Aug 2026US 2026/0226357 A1Afton Chemical Corporation
- Substituted Hydroxystilbene Compounds and Derivatives, Synthesis and Uses Thereof23 Jul 2026US 2026/0209152 A1Kynan Duke IP, LLC
- Prodrugs of itaconate and methyl itaconate23 Jul 2026US 2026/0209164 A1Institute of Organic Chemistry and Biochemistry of the AS CR, V.V.I.
- Molecular glue degrader compounds and uses thereof16 Jul 2026US 2026/0200939 A1Novartis AG
Most cited
By later US patents
- Target molecule attachment to surfaces300US 6,465,178 B2SurModics, Inc. · 2002
- Diketopiperazine-based delivery systems228US 5,976,569 AEmisphere Technologies, Inc. · 1999
- Oral drug delivery compositions and methods186US 5,792,451 AEmisphere Technologies, Inc. · 1998
- Compounds and compositions for delivering active agents184US 5,643,957 AEmisphere Technologies, Inc. · 1997
- Carbon-substituted diketopiperazine delivery systems183US 6,331,318 B1Emisphere Technologies, Inc. · 2001